Office of Regulatory Affairs

The Office of Regulatory Affairs (ORA)^[1] is the part of the U.S. Food and Drug Administration (FDA) that enforces the laws governing biologics, cosmetics, drugs, food, medical devices, radiation-emitting electronic devices, tobacco products, and veterinary products which may have potentially harmful side effects for the consumer.^[2]

The FDA Office of Regulatory Affairs is responsible for the enforcement of federal legislation and serves in a regulatory capacity to ensure health related products are accurately and informatively represented to the public, effective, and safe.

	Food portal
	Government of the United States portal
	Health and fitness portal
	Law portal
	Medicine portal

The Office of Regulatory Affairs has legislative and regulatory authority for the specified health related products:

Biologics^[3]
Cosmetics^[4]
Drugs^[5]
Foods^[6]
Medical Devices^[7]
Radiation-Emitting Electronic Products^[8]
Tobacco Products^[9]
Veterinary Products^[10]

Organization

It is organized into five regions - Northeast (NER), Central (CER), Southeast (SER), Southwest (SWR) and Pacific (PAR).^[11] Each region is structured into district and resident post offices. There are a total of 20 district offices, nineteen of which handle both imported and domestic products and one import only district (Southwest Import, referred to as "SWID").^[12] Districts, with the exception of SWID, are referred to by a three letter name followed by "DO", such as MIN-DO for Minneapolis District.

Each district office consists of three branches reporting to a district director. The majority of the staff are part of an Investigations Branch that performs routine inspections of manufacturers and imported products, issuance of the FDA 483, complaint investigations, audits of recalls, collections of samples, and other related tasks.^[13] These staff are mostly Consumer Safety Officers (CSOs, "Investigators") or Consumer Safety Inspectors (CSIs, "Inspectors"). ORA no longer routinely hire CSIs, most new staff are CSOs. These staff have a variety of administrative authorities and enforce the civil law requirements of the Food, Drug, and Cosmetic Act as well as parts of the Public Health Service Act.^[14] Some are also commissioned officers of the Public Health Service,^[15] but this does not generally affect day to day duties. These staff are generally technical or scientific and are not involved in criminal law enforcement which is handled by a separate branch of FDA called OCI, though many criminal investigations are started by ORA referring a case to OCI.

The district offices also include a Compliance Branch. Compliance Officers handle the administrative authorities used in inspections, such as issuing Warning Letters.^[16] They also organizing civil litigation (such as a seizure or injunction) which is brought to the courts by the United States District Attorneys.

The final branch is an Administrative Branch which handles budgeting, some aspects of payroll, and other administrative tasks. Regional and national regulatory experts are often located at district offices, but are not administratively part of those offices.

The districts also include resident posts, typically in major cities or at major border crossings. These are generally only Investigations Branch staff.

The Office of Regulatory Affairs operates thirteen field laboratories. The field science laboratories were historically part of the FDA districts infrastructure but are now independent entities. ORA has five regional, six district, and two specialty laboratories such as the Forensic Chemistry Center (FCC) and the Winchester Engineering and Analytical Center (WEAC).^[17]

ORA operations are generally conducted according to the Compliance Program Guidance Manual (CPGM),^[18] Investigations Operations Manual (IOM),^[19] and the Regulatory Procedures Manual (RPM).^[20]

External links

U.S. FDA Forms
U.S. FDA Guidances
U.S. FDA Inspection Guides
U.S. FDA International Inspections & Travel
U.S. FDA Laboratory Manual
U.S. FDA Medical Device Quality Systems Manual
U.S. FDA Medical Device Quality Systems Regulation/Design Controls

References

U.S. Food and Drug Administration v · Food and Drug Administration of the United States Divisions Center for Biologics Evaluation and Research · Center for Devices and Radiological Health · Center for Drug Evaluation and Research · Center for Food Safety and Applied Nutrition · Center for Tobacco Products · Center for Veterinary Medicine · National Center for Toxicological Research · Office of Criminal Investigations · Office of Regulatory Affairs Major Acts Family Smoking Prevention and Tobacco Control Act · Federal Food, Drug, and Cosmetic Act · Food Safety Modernization Act · Prescription Drug User Fee Act · Pure Food and Drug Act Commissioners Harvey W. Wiley · Carl L. Alsberg · Charles A. Browne · Walter G. Campbell · Paul P. Dunbar · Charles W. Crawford · George P. Larrick · James L. Goddard · Herbert L. Ley · Charles C. Edwards · Alexander M. Schmidt · Donald Kennedy · Jere E. Goyan · Arthur H. Hayes Jr. · Frank Edward Young · David Aaron Kessler · Jane E. Henney · Mark McClellan · Lester Crawford · Andrew von Eschenbach · Margaret Hamburg v · FDA Doesn't Regulate Advertising  • Federal Trade Commission Alcohol  • Bureau of Alcohol, Tobacco, Firearms and Explosives Consumer Products  • Consumer Product Safety Commission Drugs of Abuse  • Drug Enforcement Administration Health Insurance  • Centers for Medicare and Medicaid Services Meat and Poultry  • Food Safety and Inspection Service Pesticides  • Environmental Protection Agency  • Food and Drug Administration  • U.S. Department of Agriculture Restaurants and Grocery Stores  • Local County Health Departments Water  • Environmental Protection Agency  • Food and Drug Administration FDA Regulations & Rules Administrative Law  • Title 21 of the Code of Federal Regulations (CFR) Federal Journal  • Federal Register (FR) Federal Law  • Title 21 of the United States Code (U.S.C.) Source: U.S. FDA Office of Regulatory Affairs